The effect of deoxycytidine and tetrahydrouridine in purine nucleoside phosphorylase deficiency.
D000592:Amino Acid Metabolism, Inborn Errors / Q000628:therapy*; D002986:Clinical Trials as Topic; D003841:Deoxycytidine / Q000378:metabolism / Q000627:therapeutic use*; D004912:Erythrocytes / Q000378:metabolism; D006801:Humans; D010430:Pentosyltransferases / Q000172:deficiency*; D011683:Purine-Nucleoside Phosphorylase / Q000172:deficiency*; D012265:Ribonucleotides / Q000097:blood; D013767:Tetrahydrouridine / Q000627:therapeutic use*; D014498:Uracil / Q000378:metabolism; D014529:Uridine / Q000031:analogs & derivatives*
D012265:Ribonucleotides; D003841:Deoxycytidine; D013767:Tetrahydrouridine; D014498:Uracil; D010430:Pentosyltransferases; D011683:Purine-Nucleoside Phosphorylase; D014529:Uridine